Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Antibodies Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Monoclonal antibodies
  • 1.3.3 Polyclonal antibodies
  • 1.3.4 Antibody drug conjugates
• 1.4 Market Segment by Application
  • 1.4.1 Global Antibodies Market Share by Application (2019-2025)
  • 1.4.2 Hospitals
  • 1.4.3 Long-term care facilities
  • 1.4.4 Research institutes
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Antibodies Market Size
  • 2.1.1 Global Antibodies Revenue 2014-2025
  • 2.1.2 Global Antibodies Sales 2014-2025
• 2.2 Antibodies Growth Rate by Regions
  • 2.2.1 Global Antibodies Sales by Regions 2014-2019
  • 2.2.2 Global Antibodies Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Antibodies Sales by Manufacturers
  • 3.1.1 Antibodies Sales by Manufacturers 2014-2019
  • 3.1.2 Antibodies Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Antibodies Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antibodies Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Antibodies Market Concentration Ratio (CR5 and HHI)
• 3.3 Antibodies Price by Manufacturers
• 3.4 Key Manufacturers Antibodies Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Antibodies Market
• 3.6 Key Manufacturers Antibodies Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Monoclonal antibodies Sales and Revenue (2014-2019)
  • 4.1.2 Polyclonal antibodies Sales and Revenue (2014-2019)
  • 4.1.3 Antibody drug conjugates Sales and Revenue (2014-2019)
• 4.2 Global Antibodies Sales Market Share by Type
• 4.3 Global Antibodies Revenue Market Share by Type
• 4.4 Antibodies Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Antibodies Sales by Application

6 United States

• 6.1 United States Antibodies Breakdown Data by Company
• 6.2 United States Antibodies Breakdown Data by Type
• 6.3 United States Antibodies Breakdown Data by Application

7 European Union

• 7.1 European Union Antibodies Breakdown Data by Company
• 7.2 European Union Antibodies Breakdown Data by Type
• 7.3 European Union Antibodies Breakdown Data by Application

8 China

• 8.1 China Antibodies Breakdown Data by Company
• 8.2 China Antibodies Breakdown Data by Type
• 8.3 China Antibodies Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Antibodies Breakdown Data by Company
• 9.2 Rest of World Antibodies Breakdown Data by Type
• 9.3 Rest of World Antibodies Breakdown Data by Application
• 9.4 Rest of World Antibodies Breakdown Data by Countries
  • 9.4.1 Rest of World Antibodies Sales by Countries
  • 9.4.2 Rest of World Antibodies Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Novartis
  • 10.1.1 Novartis Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Antibodies
  • 10.1.4 Antibodies Product Introduction
  • 10.1.5 Novartis Recent Development
• 10.2 F. Hoffmann-La Roche
  • 10.2.1 F. Hoffmann-La Roche Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Antibodies
  • 10.2.4 Antibodies Product Introduction
  • 10.2.5 F. Hoffmann-La Roche Recent Development
• 10.3 Johnson & Johnson Services
  • 10.3.1 Johnson & Johnson Services Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Antibodies
  • 10.3.4 Antibodies Product Introduction
  • 10.3.5 Johnson & Johnson Services Recent Development
• 10.4 Amgen
  • 10.4.1 Amgen Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Antibodies
  • 10.4.4 Antibodies Product Introduction
  • 10.4.5 Amgen Recent Development
• 10.5 Bristol-Myers Squibb
  • 10.5.1 Bristol-Myers Squibb Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Antibodies
  • 10.5.4 Antibodies Product Introduction
  • 10.5.5 Bristol-Myers Squibb Recent Development
• 10.6 AbbVie
  • 10.6.1 AbbVie Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Antibodies
  • 10.6.4 Antibodies Product Introduction
  • 10.6.5 AbbVie Recent Development
• 10.7 Eli Lilly
  • 10.7.1 Eli Lilly Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Antibodies
  • 10.7.4 Antibodies Product Introduction
  • 10.7.5 Eli Lilly Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Antibodies Sales Channels
  • 11.2.2 Antibodies Distributors
• 11.3 Antibodies Customers

12 Market Forecast

• 12.1 Global Antibodies Sales and Revenue Forecast 2019-2025
• 12.2 Global Antibodies Sales Forecast by Type
• 12.3 Global Antibodies Sales Forecast by Application
• 12.4 Antibodies Forecast by Regions
  • 12.4.1 Global Antibodies Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Antibodies Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein produced mainly by plasma cells that is used by the immune system to neutralize pathogens such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the pathogen, called an antigen, via the Fab's variable region.
Based on types, the global antibodies market is seperated into polyclonal antibodies, monoclonal antibodies and antibody-drug conjugates. Among others, monoclonal antibodies posses the biggest market share in 2017 and is expected to increase over the forecast period.
Antibodies can be widely used in different sectorsluding hospitals, research institutions and long-term care facilities. Hospitals are the biggest downstream consumer of antibodies due to intens demand of monoclonal antibodies.
In 2019, the market size of Antibodies is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antibodies.

This report studies the global market size of Antibodies, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antibodies sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Novartis
F. Hoffmann-La Roche
Johnson & Johnson Services
Amgen
Bristol-Myers Squibb
AbbVie
Eli Lilly
...

Market Segment by Product Type
Monoclonal antibodies
Polyclonal antibodies
Antibody drug conjugates

Market Segment by Application
Hospitals
Long-term care facilities
Research institutes

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Antibodies status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antibodies manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antibodies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025